Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence

Prior treatment

• Enrollment into hospice prior to randomization

Other illness

• Previous history of other cancer diagnosis requiring chemotherapy, radiation therapy, or immunotherapy within the past 12 months;
• Contraindication to all non-surgical therapy available for endometrial cancer (i.e., chemotherapy, radiation, and immunotherapy contraindicated);
• Recent hospitalization for psychiatric illness in the past 6 months

Other

• Participants must not have any of the following exclusion criteria:
• Newly diagnosis of FIGO Stage IA Grade 1 endometrioid adenocarcinoma
• Incarcerated in a detention facility or in police custody (patients wearing a monitoring device can be enrolled) at baseline/screening;
• Unable to provide written informed consent in English;
• Unable to be contacted for research surveys;

• Adult 18 years of age or older; and
• Self-identify as Black/African American
• Presenting with high-risk EC established by anatomic pathology as tumor stage and grade classification by the following:
  • Pathology documentation from any hospital/clinic/medical center, and
  • FIGO Stage 1A with Grade 2, Grade 3, or Grade 4 of any histology type or
  • FIGO Stage 1A with non-endometrioid (carcinosarcoma, serous, clear cell, undifferentiated or mixed) histology
  • FIGO Stage 1B, 2, 3, or 4 of any grade or histology
  • Recurrent endometrial cancer of any stage or grade
• Documented provider recommendation and patient plan to initiate adjuvant therapy with chemotherapy, radiation, and/or immunotherapy.